Total Payments
$6,318
2024 Payments
$1,212
Companies
25
Transactions
406
Medicare Patients
1,799
Medicare Billing
$20,082
Payment Breakdown by Category
Food & Beverage$6,318 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,318 | 406 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,249 | 93 | $0 (2024) |
| Novo Nordisk Inc | $1,147 | 89 | $0 (2024) |
| Lilly USA, LLC | $820.05 | 56 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $791.05 | 53 | $0 (2024) |
| ABBVIE INC. | $547.40 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $411.18 | 21 | $0 (2023) |
| ViiV Healthcare Company | $200.64 | 8 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $112.62 | 6 | $0 (2023) |
| Mylan Specialty L.P. | $110.15 | 5 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $102.60 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,212 | 74 | Novo Nordisk Inc ($354.98) |
| 2023 | $1,935 | 118 | GlaxoSmithKline, LLC. ($403.65) |
| 2022 | $1,257 | 93 | Bayer HealthCare Pharmaceuticals Inc. ($267.32) |
| 2021 | $1,057 | 68 | GlaxoSmithKline, LLC. ($296.36) |
| 2020 | $629.85 | 47 | GlaxoSmithKline, LLC. ($176.80) |
| 2019 | $227.64 | 6 | GlaxoSmithKline, LLC. ($124.11) |
All Payment Transactions
406 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Cardio-renal | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: HIV | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $10.28 | General |
| Category: Cardio-renal | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Endocrinology | ||||||
| 08/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Obesity | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Cardio-renal | ||||||
| 08/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Obesity | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: HIV | ||||||
| 07/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Cardio-renal | ||||||
| 06/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 776 | 994 | $16,871 | $7,705 |
| 2022 | 9 | 479 | 560 | $13,739 | $6,587 |
| 2021 | 7 | 263 | 288 | $14,570 | $4,065 |
| 2020 | 6 | 281 | 336 | $9,393 | $1,725 |
Total Patients
1,799
Total Services
2,178
Medicare Billing
$20,082
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 325 | 475 | $2,850 | $2,788 | 97.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 33 | 33 | $2,079 | $1,659 | 79.8% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 147 | 194 | $1,843 | $764.36 | 41.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 30 | 30 | $720.00 | $620.28 | 86.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 26 | 28 | $504.00 | $454.16 | 90.1% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 105 | 109 | $6,540 | $443.07 | 6.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 18 | 18 | $324.00 | $291.60 | 90.0% |
| 92552 | Test for hearing various pitches using earphone | Office | 2023 | 14 | 14 | $588.00 | $284.10 | 48.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 33 | 38 | $266.00 | $232.18 | 87.3% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 19 | 26 | $780.00 | $100.10 | 12.8% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 26 | 29 | $377.00 | $67.28 | 17.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 77 | 85 | $5,355 | $4,311 | 80.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 124 | 156 | $936.00 | $920.98 | 98.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 19 | 19 | $342.00 | $308.51 | 90.2% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 72 | 76 | $4,560 | $286.67 | 6.3% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 63 | 70 | $665.00 | $277.64 | 41.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 65 | 92 | $874.00 | $204.97 | 23.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 26 | 26 | $182.00 | $160.00 | 87.9% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 19 | 21 | $630.00 | $82.01 | 13.0% |
| 85018 | Blood count, hemoglobin | Office | 2022 | 14 | 15 | $195.00 | $35.03 | 18.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 50 | 60 | $3,388 | $3,079 | 90.9% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2021 | 79 | 84 | $9,740 | $369.64 | 3.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 51 | 53 | $318.00 | $313.20 | 98.5% |
| 81003 | Automated urinalysis test | Office | 2021 | 41 | 48 | $456.00 | $108.00 | 23.7% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 17 | 18 | $171.00 | $72.36 | 42.3% |
About Dr. Ben Cooke, MD
Dr. Ben Cooke, MD is a Internal Medicine healthcare provider based in Atascadero, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2016. The National Provider Identifier (NPI) number assigned to this provider is 1528512803.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ben Cooke, MD has received a total of $6,318 in payments from pharmaceutical and medical device companies, with $1,212 received in 2024. These payments were reported across 406 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($6,318).
As a Medicare-enrolled provider, Cooke has provided services to 1,799 Medicare beneficiaries, totaling 2,178 services with total Medicare billing of $20,082. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Atascadero, CA
- Active Since 08/04/2016
- Last Updated 10/28/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1528512803
Products in Payments
- TRELEGY ELLIPTA (Drug) $845.54
- Kerendia (Drug) $791.05
- Ozempic (Drug) $621.98
- UBRELVY (Drug) $370.66
- JARDIANCE (Drug) $356.55
- MOUNJARO (Drug) $317.76
- Wegovy (Drug) $292.05
- TRULICITY (Drug) $234.47
- APRETUDE (Biological) $200.64
- Rybelsus (Drug) $199.12
- QULIPTA (Drug) $159.26
- STIOLTO RESPIMAT (Drug) $130.36
- AREXVY (Drug) $118.89
- EMGALITY (Drug) $117.15
- QUVIVIQ (Drug) $112.62
- ANORO ELLIPTA (Drug) $109.22
- FARXIGA (Drug) $95.97
- NURTEC ODT (Drug) $95.96
- DUPIXENT (Biological) $75.04
- AVYCAZ (Drug) $68.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Atascadero
Dr. Jason Green, M.d, M.D
Internal Medicine — Payments: $3,391
Internal Medicine $3,391
Lymar Bik, M.d, M.D
Internal Medicine — Payments: $2,086
Internal Medicine $2,086
Robin Alleyne, Md, MD
Internal Medicine — Payments: $394.29
Internal Medicine $394.29
Madeleine Hernandez, Md, MD
Internal Medicine — Payments: $392.71
Internal Medicine $392.71
Ms. Emily Luk, M.d, M.D
Internal Medicine — Payments: $124.56
Internal Medicine $124.56
Hossein Akhavan, M.d, M.D
Internal Medicine — Payments: $117.40
Internal Medicine $117.40